Francis Pang

998 total citations
27 papers, 692 citations indexed

About

Francis Pang is a scholar working on Physiology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Francis Pang has authored 27 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 4 papers in Epidemiology and 4 papers in Economics and Econometrics. Recurrent topics in Francis Pang's work include Lysosomal Storage Disorders Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Francis Pang is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Francis Pang collaborates with scholars based in United Kingdom, United States and Japan. Francis Pang's co-authors include Mark Sculpher, Andrea Manca, Su Golder, Linda Davies, Michael Drummond, Alison Eastwood, J. Edington, R.J. Stratton, Colin A. Russell and Marinos Elia and has published in prestigious journals such as Bioresource Technology, Lara D. Veeken and Health Technology Assessment.

In The Last Decade

Francis Pang

23 papers receiving 655 citations

Peers

Francis Pang

PHYSI

GHP

PMH

Hélène Chevrou‐Séverac Switzerland

France Vrijens United States

Claudia M. Lora United States

Anita Ambs United States

Christopher Zacker United States

Wai Leng Chow Singapore

Birkan İlhan Türkiye

Yvette Meuleman Netherlands

Priscilla Perez da Silva Pereira Brazil

Linda Lillington United States

Hélène Chevrou‐Séverac Switzerland

Francis Pang

106 ×0.4

PHYSI

378 ×1.6

145 ×1.1

GHP

70 ×0.6

31 ×0.3

PMH

Citations per year, relative to Francis Pang Francis Pang (= 1×) peers Hélène Chevrou‐Séverac

Countries citing papers authored by Francis Pang

Since Specialization

Citations

This map shows the geographic impact of Francis Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Pang more than expected).

Fields of papers citing papers by Francis Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Pang. The network helps show where Francis Pang may publish in the future.

Co-authorship network of co-authors of Francis Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Francis Pang. A scholar is included among the top collaborators of Francis Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis Pang. Francis Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Qun, et al.. (2025). Enhanced lipid production in Chlorella vulgaris via indole-3-acetic acid salt stress in a two-stage culture for biofuels. Biochemical Engineering Journal. 221. 109795–109795. 1 indexed citations

Pang, Francis, et al.. (2025). Optimizing algal-bacterial systems for efficient sugar cane wastewater treatment: Pollutant removal and biomass resource recovery. Bioresource Technology. 429. 132497–132497. 1 indexed citations

Armstrong, Nigel, Andrew Olaye, Caro Noake, & Francis Pang. (2023). A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel. Orphanet Journal of Rare Diseases. 18(1). 248–248. 5 indexed citations

Bean, Karen, et al.. (2023). EE547 The Societal Costs of Metachromatic Leukodystrophy (MLD) in the United States. Value in Health. 26(12). S157–S158. 1 indexed citations

Bean, K., et al.. (2022). POSB95 The Cost-Effectiveness of Newborn Screening for Metachromatic Leukodystrophy (MLD) in the UK. Value in Health. 25(1). S79–S79. 1 indexed citations

Eichler, Florian, et al.. (2022). Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy. Orphanet Journal of Rare Diseases. 17(1). 370–370. 8 indexed citations

Sevin, Caroline, et al.. (2022). An international study of caregiver-reported burden and quality of life in metachromatic leukodystrophy. Orphanet Journal of Rare Diseases. 17(1). 329–329. 14 indexed citations

Eichler, Florian, et al.. (2021). Initial signs and symptoms of metachromatic leukodystrophy: A caregiver perspective. Molecular Genetics and Metabolism. 132(2). S36–S36.

Nafees, Beenish, et al.. (2020). PRO131 A Societal Utility Study to Elicit Values for Stages of Metachromatic Leukodystrophy (MLD) in the United Kingdom. Value in Health. 23. S713–S713. 3 indexed citations

10.

Kobayashi, M, et al.. (2018). An Economic Evaluation of Migalastat Versus ERT for the Treatment of Fabry Disease in Japan. Value in Health. 21. S109–S109. 2 indexed citations

11.

Beusterien, Kathleen, et al.. (2012). Development of the multi-attribute Adolescent Health Utility Measure (AHUM). Health and Quality of Life Outcomes. 10(1). 102–102. 27 indexed citations

12.

Walsh, Ceara AE, Patricia Minnock, Catherine F. Slattery, et al.. (2007). Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis. Lara D. Veeken. 46(7). 1148–1152. 27 indexed citations

13.

Pritchard, Clive, Steven Duffy, J. Edington, & Francis Pang. (2006). Enteral Nutrition and Oral Nutrition Supplements: A Review of the Economics Literature. Journal of Parenteral and Enteral Nutrition. 30(1). 52–59. 33 indexed citations

14.

Edington, J., Gary Frost, Mary Hickson, et al.. (2003). A prospective randomised controlled trial of nutritional supplementation in malnourished elderly in the community: clinical and health economic outcomes. Clinical Nutrition. 23(2). 195–204. 100 indexed citations

15.

Edington, J., et al.. (2003). A survey of screening and nutritional management in hospitals and the community. Clinical Nutrition. 22. S98–S99. 1 indexed citations

16.

Wells, Nicholas, et al.. (2003). A Cost-Effectiveness Analysis of Eletriptan 40 and 80 mg versus Sumatriptan 50 and 100 mg in the Acute Treatment of Migraine. Value in Health. 6(4). 438–447. 20 indexed citations

17.

Pang, Francis. (2002). Design, Analysis and Presentation of Multinational Economic Studies. PharmacoEconomics. 20(2). 75–90. 30 indexed citations

18.

Bergemann, R, et al.. (2002). PAR3 VARIATION IN RESOURCE UTILIZATION AND TREATMENT COSTS FOR RHEUMATOID ARTHRITIS (RA) ACROSS 5 COUNTRIES IN AN ADALIMUMAB (D2E7) CLINICAL TRIAL. Value in Health. 5(6). 475–476. 2 indexed citations

19.

Pang, Francis. (2001). The Generalisabilityof Economic Evaluation. 6(1). 69–82. 1 indexed citations

20.

Pang, Francis. (1999). TPL2: MULTINATIONAL ECONOMIC EVALUATIONS: A REVIEW OF PUBLISHED STUDIES, METHODOLOGICAL ISSUES AND PRACTICE. Value in Health. 2(5). 380–380. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact